MAYNE PHARMA USA INC. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for MAYNE PHARMA USA INC.

Sort by

Viewing results 1‒25 of 26

Walgreens Boots Alliance Inc
Walgreens Boots sticks with guidance as US pharma sales improve
...In particular, WBA pointed to a 2.3 per cent year-on-year rise in sales at its main Retail Pharmacy USA division, with a rise in pharmacy sales offsetting declining retail sales....
June 27, 2019
Equities
Markets Now - Monday 27th July 2020
...Our 10% WACC remains a premium to our mid-cap pharma peer average 8.6% which reflects our view of increased risk around single product execution....
July 27, 2020
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Equities
Markets Now - Monday 8th June 2020
...Campari will be hard hit by COVID-19 due to high On Trade exposure, especially in core markets of Italy and the USA....
June 8, 2020
Novartis AG
Head of Novartis generic drugs business steps down
...In September last year, Novartis said it would sell parts of the Sandoz US business to Aurobindo Pharma USA to focus on “higher growth areas”....
March 14, 2019
European companies
Novartis offloads part of Sandoz generics business in US
...On Thursday, Novartis said it would sell portions of the Sandoz US portfolio to Aurobindo Pharma USA in order to focus on “higher growth areas”....
September 6, 2018
On Wall StreetSujeet Indap
Why the Delaware ruling on Akorn-Fresenius deal matters
...In April last year Fresenius, a large German medical products group, announced an acquisition of American generics pharma company Akorn for nearly $5bn....
October 20, 2018
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Pharmaceuticals sector
Mylan drops as AGs look to expand generic drug-pricing lawsuit
...The companies now under investigation are: Heritage Pharmaceuticals, Inc.; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA;...
October 31, 2017
Pharmaceuticals sector
Health care stocks fall after Trump comments on drug pricing
...Australian generic drug maker Mayne Pharma Group, which derives 87 per cent of its revenue from the United States according to Bloomberg data, dropped 2.6 per cent....
January 12, 2017
Tobacco
FT Health: Diseases less neglected
.... ———- Chartwatch Drug donations Pharma companies provide more than 1.8bn treatments a year for neglected tropical diseases....
April 21, 2017
Pharmaceuticals sector
20 states sue generic drug companies over pricing
...The states’ lawsuit said that the six generic drug makers – which also include Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma and Mayne Pharma – “entered into illegal conspiracies in order...
December 15, 2016
US politics & policy
Drug stocks tumble as Trump singles out pharma companies
...Mayne Pharma shed 2.6 per cent....
January 12, 2017
Mergers & Acquisitions
Mayne Pharma surges 37% after Teva deal
...Mayne Pharma into the top 25 retail generic pharmaceutical companies and the top 2 in the generic oral contraceptives market in the United States.”...
June 30, 2016
News in-depthSocial Media
Corporate year in review
...The move quickly spurred market speculation that Mr Son would revive talks for a merger between SoftBank-owned Sprint and rival T-Mobile USA....
December 24, 2016
FT AlphavilleDavid Keohane
The 6am London Cut
...KKR will acquire the minority stake in Gland Pharma, including the entire stake held by private equity fund, Evolvence India Life science Fund, in the Hyderabad-based firm, KKR said in a statement.”...
November 28, 2013
beyondbricsMarkets
Ranbaxy pleads guilty and settles US felony but outlook remains unclear
...Related reading: Ranbaxy: losses, again, beyondbrics India pharma: Strides Arcolab in $1.6bn deal with US generics maker Mylan, beyondbrics India: pharma companies sales to suffer on new round of price controls...
May 14, 2013
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
LexUS & Canadian companies
Nestlé’s Nespresso – pod race
...Nestlé is not the first to face this sort of problem – razor makers, printer manufacturers and pharma companies all like to tie customers in to buying their consumables, but face competition from generic...
August 17, 2012
Asia-Pacific companies
Primary may make offer for Symbion
...Symbion was created in 2005 from the split of Australia’s Mayne Group into hospital and pharmaceuticals units. In January, Mayne Pharma was acquired by US group Hospira for A$2bn....
September 3, 2007
Mergers & Acquisitions
Mayne Pharma looks set for bidding war
...Mayne Pharma’s shares closed at A$4.16, compared with the A$4.10 a share offered by Hospira, which represented a 32 per cent premium over the closing price on Monday, before Mayne shares were suspended from...
September 21, 2006
Asia-Pacific equities
Hospira to buy Australia’s Mayne for $2bn
...Shares of Mayne Pharma soared 36 per cent on the news on Thursday. On Wednesday, Hospira shares rose 1.9 per cent to $37.55....
September 21, 2006
Q&AEurozone economy
Investment strategies in turbulent times
...David Drane, Dorset Tim Price: The gloom in relation to US Inc is probably overdone....
November 12, 2007
US & Canadian companies
Danaher takes lead in Vision Systems fight
...Pharma, an Australian supplier of generic drugs....
October 9, 2006
Asia-Pacific companies
Ventana and Danaher eye joint Vision bid
...Hospira, the US pharmaceuticals group, last month said it was in advanced talks to acquire Mayne Pharma, the Australian injectable drugs specialist, in a deal worth about US$2bn....
October 3, 2006
US & Canadian companies
Ventana ahead in 3-way battle for Vision
...Meanwhile, Hospira, a spin-off from Abbott, offered A$2.5bn in cash for Mayne Pharma, an Australian supplier of generic drugs....
September 28, 2006
Companies
Isoft gets a bit cross with the Maltese
...Her new job is head of external communications at Mayne Pharma, a specialist in injectable cancer drugs. mudlark@ft.com...
August 2, 2006
UK schools
Ask the experts: Should old media embrace new?
...Larry Lynch, USA Tom Glocer: I think there’s always going to be a role for newspapers....
March 15, 2006

Previous pagePage 1 of 2Next page